Physician profile
Eric N Klein
NPI 1720260920
$11,234.79
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2022: $20.61 · 2024: $72.90 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $1,587 · Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $1,586.92 |
| Food and Beverage | $1,006.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,243.41 | 2025 | |
| Davol INC. | $350.59 | 2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $187.31 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2025 | |
| Acell, INC. | $120.42 | 2019 | |
| Boston Scientific Corporation | $114.55 | 2025 | Spyglass Discover |
| Medical Device Business Services, INC. | $72.90 | 2024 | Matrixrib |
| Takeda Pharmaceuticals U.S.A., INC. | $20.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.